Lifestyle & Behaviors Core, Vos
Lifestyle & Behaviors Core, Vos
批准号:
10260486
负责人:
MIRIAM B. VOS
金额:
$10.97万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-10 至 2023-07-31
关键词:
AdultAreaAwarenessBehaviorBehavior assessmentBiological ProcessCardiopulmonaryChildClinicClinicalClinical InvestigatorClinical ResearchCollaborationsCollectionCommunitiesCommunity SurveysConsultationsCystic FibrosisDataData AnalysesData CollectionDatabasesDietDietary AssessmentDietary intakeEvaluationExerciseExercise TestExercise ToleranceExperimental DesignsFamilyFoundationsFundingFutureGasesGoalsHealthHomeInpatientsInterdisciplinary StudyInternationalKnowledgeLifeLife StyleLiteratureLongevityLung diseasesLung infectionsMedicalMetabolicMethodologyMissionNational Institute of Diabetes and Digestive and Kidney DiseasesOutcomeOutpatientsPerformancePhenotypePhysical activityPositioning AttributeProtocols documentationQuality of lifeResearchResearch PersonnelRoleServicesSleepSurveysSurvival RateTestingTherapeutic InterventionTrainingTranslatingTranslational ResearchTranslationsVoiceactigraphybasebehavior changebehavior measurementbehavioral outcomebiobehaviorclinical investigationcomorbiditycystic fibrosis patientscystic fibrosis related diabetesdata disseminationdata warehousediet and exerciseexercise capacityinstrumentinterestmortalityneglectnovelpeerpoor sleeppulmonary functionranpirnasesleep behaviortooltraining project
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY – Core 3: Lifestyle and Behaviors Core
There have been considerable advances in research and medical therapies for cystic fibrosis (CF);
however, therapeutic interventions for non-pulmonary, systemic manifestations have been neglected.
Fortunately, the median survival rate in CF is on the rise. Therefore, a paradigm shift to focus on
modifiable lifestyle and behavioral outcomes that will enable long-term quality of life in CF is
critically needed. Individuals with CF are less physically active than their peers and lower exercise
capacity is associated with greater mortality, steeper decline in pulmonary function, and more
pulmonary infections. Sleep is an essential, restorative, biologic process crucial for maintaining and
optimizing health. Poor sleep in CF has not only been associated with progressive lung disease, but
also reduced quality of life and daytime performance. Diet has long been a cornerstone of CF therapy;
however, diet quality has not been a focus and its role within the changing landscape of CF or its effects
on co-morbidities (such as CF-related diabetes) and long-term health are unknown. The overall goal
of the Lifestyle & Behaviors Core (LBC) within the Georgia CF Core Center is to bring advanced
methodologies to CF-focused research and to accelerate translational, bio-behavioral research
comprised of exercise, physical activity, diet, and sleep outcomes in people with CF. This Core will fill
a critical knowledge gap by increasing awareness, educating and disseminating knowledge, and
supporting the integration of important lifestyle and behavioral measurements and outcomes into
clinical investigations across the lifespan. This will be accomplished by three Aims, as follows:
Aim 1. To provide training, project-specific consultation and support for assessing, collecting,
and interpreting exercise, physical activity, diet, sleep and behavior change data in CF studies.
Aim 2. To enhance the utilization and integration of instruments and tools related to lifestyle and
behaviors into clinical and translational research in children and adults with CF.
Aim 3. To incorporate extensive phenotyping of lifestyle and behavior outcomes into the
longitudinal Georgia CF Data Warehouse hosted by the Core Center.
The proposed LBC is unique among the currently funded P30 CF Centers. Successful implementation
of this core will enable Center Investigators to undertake research to focus on the interaction of lifestyle
and behavioral outcomes that are essential for the control of CF related diabetes, the primary focus of
this P30 application, and other comorbidities and conditions within the mission of the NIDDK.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sibling Assessment in Prevention of Pediatric NAFLD in Hispanic Children
-
批准号:10675355
-
项目类别:
-
资助金额:$37.01万
-
财政年份:2022
-
负责人:MIRIAM B. VOS
-
依托单位:
Prevention of Pediatric NAFLD in Hispanic Children
-
批准号:10552057
-
项目类别:
-
资助金额:$57.61万
-
财政年份:2021
-
负责人:MIRIAM B. VOS
-
依托单位:
Prevention of Pediatric NAFLD in Hispanic Children
-
批准号:10383660
-
项目类别:
-
资助金额:$58.54万
-
财政年份:2021
-
负责人:MIRIAM B. VOS
-
依托单位:
Biomarker Discovery for Nonalcoholic Fatty Liver Disease in Children
-
批准号:10469568
-
项目类别:
-
资助金额:$34.16万
-
财政年份:2020
-
负责人:MIRIAM B. VOS
-
依托单位:
Biomarker Discovery for Nonalcoholic Fatty Liver Disease in Children
-
批准号:10119937
-
项目类别:
-
资助金额:$35.43万
-
财政年份:2020
-
负责人:MIRIAM B. VOS
-
依托单位:
Biomarker Discovery for Nonalcoholic Fatty Liver Disease in Children
-
批准号:10264938
-
项目类别:
-
资助金额:$34.15万
-
财政年份:2020
-
负责人:MIRIAM B. VOS
-
依托单位:
Anti-LPS antibody for Pediatric Nonalcoholic Fatty Liver Disease
-
批准号:9335406
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2016
-
负责人:MIRIAM B. VOS
-
依托单位:
Anti-LPS antibody for Pediatric Nonalcoholic Fatty Liver Disease
-
批准号:9168600
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2016
-
负责人:MIRIAM B. VOS
-
依托单位:
National Exposure Assessment Laboratory at Emory
-
批准号:9062180
-
项目类别:
-
资助金额:$78.5万
-
财政年份:2015
-
负责人:MIRIAM B. VOS
-
依托单位:
STOPNASH Meeting
-
批准号:8986466
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2015
-
负责人:MIRIAM B. VOS
-
依托单位:
A Pilot Study of Losartan in the Treatment of Pediatric NAFLD
-
批准号:8512111
-
项目类别:
-
资助金额:$8.02万
-
财政年份:2013
-
负责人:MIRIAM B. VOS
-
依托单位:
Dietary Fructose and Redox Effects in Pediatric Nonalcoholic Fatty Liver Disease
-
批准号:7806842
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2008
-
负责人:MIRIAM B. VOS
-
依托单位:
Dietary Fructose and Redox Effects in Pediatric Nonalcoholic Fatty Liver Disease
-
批准号:8122141
-
项目类别:
-
资助金额:$17.41万
-
财政年份:2008
-
负责人:MIRIAM B. VOS
-
依托单位:
Dietary Fructose and Redox Effects in Pediatric Nonalcoholic Fatty Liver Disease
-
批准号:8322772
-
项目类别:
-
资助金额:$17.34万
-
财政年份:2008
-
负责人:MIRIAM B. VOS
-
依托单位:
Dietary Fructose and Redox Effects in Pediatric Nonalcoholic Fatty Liver Disease
-
批准号:7588223
-
项目类别:
-
资助金额:$17.41万
-
财政年份:2008
-
负责人:MIRIAM B. VOS
-
依托单位:
Dietary Fructose and Redox Effects in Pediatric Nonalcoholic Fatty Liver Disease
-
批准号:7917423
-
项目类别:
-
资助金额:$17.41万
-
财政年份:2008
-
负责人:MIRIAM B. VOS
-
依托单位:
Dietary Fructose and Redox Effects in Pediatric Nonalcoholic Fatty Liver Disease
-
批准号:7687979
-
项目类别:
-
资助金额:$17.41万
-
财政年份:2008
-
负责人:MIRIAM B. VOS
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: